Illumina

Sr. District Sales Manager

Tennessee, United States

Illumina Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, HealthcareIndustries

Requirements

Candidates should possess a minimum of 12 years of sales experience in the Life Science industry, along with at least 1-3 years of sales management experience in the same field. They should have a solid understanding of genetics and genomics, strong competency in working in a matrixed environment, and experience with capital sales. Applicants must be able to effectively communicate and influence audiences using both oral and written skills. A Bachelor’s degree, potentially with an advanced degree, in an applicable field is required.

Responsibilities

The Sr. District Sales Manager will oversee and inspire the district sales team, taking ownership of district revenue and forecasting, ensuring sales staff achieve forecasts, and developing district business plans to meet assigned budgets. They will be responsible for the recruitment, development, retention, and management of the sales team, coordinating with other departments, and monitoring team performance. Additionally, the role involves establishing territory quotas, controlling expenses, ensuring customer satisfaction, and providing training and support to the sales team, all while upholding Illumina’s values.

Skills

Sales Leadership
Forecasting
Customer Relationship Management
Team Management
Strategic Planning
Technical Sales
Salesforce

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI